The comparison of clinical features of ILD were made among DM with negative MSA/MAA,MDA5+DM (DM patients with positive anti-MDA5 antibody) (n=175) and ASS (patients with positive anti-aminoacyl tRNA synthetases antibodies (n=158)patients in our cohort (Table 1). This evidence concerns the gene IFIH1 and dermatomyositis.